Renal Cell Carcinoma

Filter By:
04:30
When cancer spreads, we are suddenly thrust into the fight of our lives for ourselves and for those we love. Join us and help change the stigma of advanced cancer from "dying with cancer" to " living with cancer" Gonna BEAT This Thing is a YES (www.beatlive...) awareness campaign created to help raise attention and i...
by:SayYEStoHOPE | 133 views
02:17
Dr Hans Hammers (Johns Hopkins, MD) discusses highlights from the Thirteenth International Kidney Cancer Symposium. Immunotherapies have received significant interest: immune checkpoint inhibitors have the potential to durably control disease. Although significant progress has been made in the clear...
by:EMJ | 278 views
07:35
At the Thirteenth International Kidney Cancer Symposium, Dr James Brugarolas (University of Texas Southwestern Medical Center, TX) discusses the clinical significance of biologically classifying kidney cancer. Advances in genome sequencing methods allowed the identification of a range of mutatio...
by:EMJ | 174 views
04:44
At the Thirteenth International Kidney Cancer Symposium, Dr James Hsieh (Memorial Sloan-Kettering Cancer Center, NY) discusses the progress in cancer understanding that has improved clinical management. Advances in technologies, including next-generation sequencing methods, have revolutionised resea...
by:EMJ | 163 views
02:57
At the Thirteenth International Kidney Cancer Symposium, Dr James Hsieh (Memorial Sloan-Kettering Cancer Center, NY) discusses the need for clinical trials in non-clear cell renal cell carcinoma (RCC) and new research in papillary RCC (pRCC). Emerging trials in the non-clear cell RCC subtype, pRCC, ...
by:EMJ | 215 views
02:56
At the Thirteenth International Kidney Cancer Symposium, Dr JianJun Gao (The University of Texas MD Anderson Cancer Center, TX) discusses papillary renal cell carcinoma (pRCC) and prospective immunotherapy. pRCC is a relatively uncommon subtype of renal cell carcinoma (RCC) that is distinct from...
by:EMJ | 213 views
02:22
At the Thirteenth International Kidney Cancer Symposium, Dr Abraham Ari Hakimi (Memorial Sloan-Kettering Cancer Center, NY) discusses recent developments in the research of kidney cancer management. Identification of cancer subtypes through molecular profiling may guide future trial design and ma...
by:EMJ | 153 views
03:00
At the Thirteenth International Kidney Cancer Symposium, Dr Laurence Albiges (Gustave Roussy, France) provides an overview of papillary renal cell carcinoma (pRCC) and management options for these patients. pRCC comprises 10–15% of renal cell carcinoma and specific therapies are not available. There...
by:EMJ | 283 views
06:12
At the Thirteenth International Kidney Cancer Symposium, Dr Toni Choueiri (Dana-Farber Cancer Institute and Harvard Medical School, MA) discusses the new AstraZeneca-spo​nsored Phase 2 clinical trial on the c-Met inhibitor, volitinib, in patients with papillary renal cell carcinoma (pRCC). pRCC i...
by:EMJ | 454 views
02:18
At the Thirteenth International Kidney Cancer Symposium, Prof David Kwiatkowski (Brigham and Women's Hospital, MA) discusses targeting the mTOR pathway in kidney cancer treatment. It may be clinically necessary to target different proteins, mTOR, TSC1 and TSC2, of the mTOR pathway. Mutations in gene...
by:EMJ | 103 views
Please help us provide the best service.
I'm intersted in oncology videos because I'm a...

Oncologist 
Different type of MD 
Nurse 
Other oncology Professional 
Patient/Advocate 
Something Else 

No Thanks(close window)
Membership has its privileges.
 I want the OncologyTube newsletter 

 I want to share videos & receive the newsletter 

I already have an account log me in.


username:   password: remember me

Sign In

Username:
Password:
Remember me
Forgot your password?
Not Yet a Member? Sign up for FREE here!
(Skip Ad)